Ymmunobio Signs Transfer Ownership Agreement with Nagoya University for NPTXR antibodies

Research indicates that NPTXR may have utility for treatment of gastro-intestinal cancers.

Read more here: https://www.prnewswire.com/news-releases/ymmunobio-signs-transfer-ownership-agreement-with-nagoya-university-for-nptxr-antibodies-301733781.html